About EUSA | People | Portfolio | Partners & Investors | News | Site Map | Contact

Products

Kidrolase®

KIDROLASE®: 10,000 I.U.,
powder for solution for injection.
(INN: Escherichia coli L-asparaginase)
KIDROLASE® is indicated in the treatment of Acute Lymphoblastic Leukaemia
Asparagine is an amino acid that is essential for cell growth; it is produced by most cells, but not all blood cells. Mutated (cancer) cells in ALL rely on asparagine circulating in the blood for growth. L-Asparaginase is an enzyme that lowers circulating asparagine levels in the blood thereby depriving the mutated blood cells of asparagine and inhibiting their growth.

KIDROLASE® is registered in 17 countries. In countries where KIDROLASE is not yet registered, pon the request of a physician KIDROLASE may be made available to named patients that fulfill defined criteria.

For information on our products, where they are available and prescribing information, please see the Product Summary table.

Download PDF
SMPC EU: Download PDF

 

KIDROLASE®

 

Portfolio
Erwinase®
Rapydan®
Collatamp®
Kidrolase®
Fomepizole
Xenazine®

Product Summary

Pipeline

Business Development
Opportunities

 

 
Back to home page Disclaimer | Legal
Registered in England 4555273 Registered Office The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA